Relationship between Family Knowledge and Compliance in Medication for Schizophrenia Outpatient at Prof. M. Ildrem Mental Hospital

Nanda Nuralita; Dita Khairunisa

doi:10.3889/oamjms.2022.9280

Authors

Nanda Nuralita Department of Psychiatry, Faculty of Medicine, Universitas Muhammadiyah Sumatera Utara, Medan, Indonesia
Dita Khairunisa Department of Psychiatry, Faculty of Medicine, Universitas Muhammadiyah Sumatera Utara, Medan, Indonesia

DOI:

https://doi.org/10.3889/oamjms.2022.9280

Keywords:

Compliance to taking medication, Family knowledge, Schizophrenia outpatient

Abstract

BACKGROUND: Schizophrenia is a global health problem that demands care and support. Compliance with taking medication for schizophrenia patients is influenced by the efficacy of taking medication, support for patients, side effects of drugs, and patient attitudes. The family is the closest person to the patient who has an important role in the patient’s recovery.

AIM: The objective of the was to determine the relationship between family knowledge and compliance with schizophrenia outpatient at Prof. M. Ildrem Mental Hospital.

METHODS: This study was a comparative analytic study using a cross-sectional design. Questionnaire data obtained from 50 respondents of schizophrenia patients and 50 of their families were processed and then analyzed using the Chi-square test.

RESULTS: Chi-square test with p = 0.008, <α 0.05, indicating that there is a relationship between family knowledge and adherence to medication in schizophrenia outpatients.

CONCLUSION: Many factors affect compliance in the treatment of schizophrenic patients, one of which is the level of family knowledge about schizophrenia. Family knowledge about schizophrenia is very important, because the higher the level of family knowledge about schizophrenia, the patient’s adherence to treatment will also be better.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Plum Analytics Artifact Widget Block

References

Volkan K. Schizophrenia: Epidemiology, causes, neurobiology, pathophysiology, and treatment. J Health Med Sci. 2020;3(4):487-521. https://doi.org/10.31014/aior.1994.03.04.143 DOI: https://doi.org/10.31014/aior.1994.03.04.143

Orrico-Sánchez A, López-Lacort M, Muñoz-Quiles C, Sanfélix- Gimeno G, Díez-Domingo J. Epidemiology of schizophrenia and its management over 8-years period using real-world data in Spain. BMC Psychiatry. 2020;20(149):1-9. DOI: https://doi.org/10.1186/s12888-020-02538-8

Kementerian kesehatan RI; Badan Penelitian dan Pengembangan Kesehatan Kementrian Kesehatan RI2013. Bakri Husada; 2013. Available from: http://www.litbang.depkes.go.id [Last accessed on 2016 May 05].

Gelder MG, Lopez-lbor JJ, Andreasen NC. Psychosis in New Oxford Textbook of Psychiatry. Oxford: Oxford University Press; 2003. p. 261-3.

Kaplan HI, Sadocks BJ. Skizofrenia in Comprehensive Textbook of Psychiatry. 9th ed. Philadelphia, PA: Lippincott Williams and Wilkins; 2009. p. 685-703.

Irmansyah E. Faktor Genetika Pada Skizofrenia. Indonesia: Program Pascasarjana Universitas Diponegoro Semarang; 2009.

Tomb D. Gangguan psikotik: Buku Saku Psikiatri. 6th ed. Jakarta: Penerbit Buku Kedokteran EGC; 2004. p. 24-5.

Sajatovic M, Mbwambo J, Lema I, Blixen C, Aebi ME, Wilson B, et al. Correlates of poor medication adherence in chronic psychotic disorders. Br J Psychiatry. 2021;7(23):1-7. DOI: https://doi.org/10.1192/bjo.2020.141

Febriana B, Susanto W, Rochmawati DH, Setiawati WE. Family support is the key to compliance with the treatment of relapsing schizophrenia patients. J Ners. 2020;15(2):457-61. DOI: https://doi.org/10.20473/jn.v15i1Sp.20361

Fakhruddin T. Hubungan Dukungan Sosial dengan Kepatuhan Minum Obat Penderita Skizofrenia Kabupaten Aceh Barat Daya. Indonesia: Program Pendidikan Sarjana Fakultas Kedokteran Universitas Syiah Kuala; 2012.

Subedi S, Paudel K, Thapa DV. Treatment non compliance in patients with schizophrenia. J Univ Coll Med Sci. 2020;8(21):3-8. https://doi.org/10.4088/jcp.v63n1206 PMid:12523871 DOI: https://doi.org/10.3126/jucms.v8i1.29773

Setiadi AI. Masalah Psikiatri. Bandung: Refika Aditama; 2007.

Zygmunt A, Olfson M, Boyer CA, Mechanic D. Interventions to improve medication adherence in schizophrenia. Am J Psychiatry. 2002;159:10. https://doi.org/10.1176/appi.ajp.159.10.1653 PMid:12359668 DOI: https://doi.org/10.1176/appi.ajp.159.10.1653

Depdikbud. Kamus Besar Bahasa Indonesia. Jakarta.Balai Pustaka; 2017.

Chowdhurry FM, Pattel D, George MG, Callahan D. Medication Adherence in CDC’S Noon Conference. Atlanta: CDC; 2013. p. 5-6.

Niven N. Psikologi Kesehatan. Jakarta: Penerbit Buku Kedokteran EGC; 2002. p. 25-28.

Feuerstein R, Hoffman M, Rand Y, Jensen M, Tzuriel D. Learning to learn: Mediated learning experience and instrumental enrichment. Spec Serv Schools 1986;3:49-63. DOI: https://doi.org/10.1300/J008v03n01_05

Farhondeh S, Maryam S, Arash M. Effect of a Psycho-educational intervention fot family members on caregiver burdens and psychiatric symptoms in patients with schizophrenia in Shiraz, Iran. BMC Psychiatry 2012;12:48. https://doi.org/10.1186/1471-244X-12-48 PMid:22632135 DOI: https://doi.org/10.1186/1471-244X-12-48

Wulansih S, Widodo A. Hubungan Antara Tingkat Pengetahuan dan Sikap Keluarga Dengan Kekambuhan Pada Pasien Skizofrenia di RSJD Surakarta. In Universitas Muhammadiyah Surakarta. Surakarta: Publikasi Ilmiah; 2008.

Yu W, Tong J, Sun X, Chen F, Zhang J, Pei Y, et al. Analysis of medication adherence and its influencing factors in patients with schizophrenia in the Chinese institutional environment. Int J Environ Res Public Health. 2021;18(4746):1-10. https://doi.org/10.3390/ijerph18094746 PMid:33946836 DOI: https://doi.org/10.3390/ijerph18094746

Nuralita NS, Camellia V, Loebis B. relationship between caregiver burden and expressed emotion in families of schizophrenic patients. Repub Maced Open Access Maced J Med Sci. 2019;7(16):2583-9. DOI: https://doi.org/10.3889/oamjms.2019.394

Nuralita NS, Thristy II, Lubis DM. Relationship between polymorphism of angiotensin converting enzyme gene with symptoms of depression in schizophrenic patients. Bul Farm. 2022;7(1):13-4. DOI: https://doi.org/10.30596/bf.v7i1.9483

Safira Z, Nuralita NS, Gultom DP, Lubis M. Perbedaan kadar gula darah pada pasien skizofrenia yang menggunakan obat haloperidol dan risperidon Di RSJ. PROF. DR. M. ILDREM. J Ilmiah Maksitek. 2021;6(4):28-33.